AGTHERA INC.
General Probiotics (GP) is a biotechnology company that discovers, develops and commercializes a new class of antimicrobial medicines for infectious diseases. GP engineers are world leaders in advanced probiotics. GP probiotics are tailored to eliminate pathogens effectively and reliably. GP has been awarded Small Business Innovative Research grants by the US National Science Foundation and the US Department of Agriculture to pursue an unparalleled, AI-enabled R&D program.
AGTHERA INC.
Social Links:
Industry:
Artificial Intelligence (AI) Biotechnology Life Science Therapeutics
Founded:
2014-01-01
Address:
Saint Paul, Minnesota, United States
Country:
United States
Website Url:
http://www.agthera.com
Total Employee:
1+
Status:
Active
Contact:
651-503-2696
Email Addresses:
[email protected]
Total Funding:
1.39 M USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured

Founder
Investors List
![]()
National Science Foundation
National Science Foundation investment in Grant - AgThera Inc.
![]()
National Science Foundation
National Science Foundation investment in Grant - AgThera Inc.
![]()
National Science Foundation
National Science Foundation investment in Grant - AgThera Inc.
Official Site Inspections
http://www.agthera.com
- Host name: notaria2mzo.com.mx
- IP address: 162.144.1.202
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606

More informations about "AgThera Inc."
About โ AGTHERA
AgThera and its sister company, General Probiotics, have been awarded Phase I/II/IIb Small Business Innovative Research grants by the US National Science Foundation and the USDA โฆSee details»
AgThera 2025 Company Profile: Valuation, Funding & Investors
AgThera General Information Description. Developer of a biotechnology platform designed to discover, develop, and commercialize a new class of antibacterial and antiviral medicines for โฆSee details»
AgThera Inc. - Crunchbase Company Profile & Funding
Organization. AgThera Inc. Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. General Probiotics develops innovative cellbots, โฆSee details»
AgThera Inc. - LinkedIn
AgThera discovers a new class of antibacterial and antiviral living medicines for infectious diseases. With synthetic biology techniques we engineer hundreds of variant antimicrobial โฆSee details»
AgThera Company Profile | Management and Employees List
AGTHERA specializes in advanced probiotics and live therapeutics aimed at combating global food insecurity by enhancing the production of sustainable and healthy animal protein. The โฆSee details»
AgThera Inc. - Org Chart, Teams, Culture & Jobs - The Org
View AgThera Inc.'s up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
AgThera - Overview, News & Similar companies | ZoomInfo.com
Who is AgThera. AgThera discovers a new class of antibacterial and antiviral living medicines for infectious diseases.With synthetic biology techniques we engineer hundreds of variant โฆSee details»
AgThera - Products, Competitors, Financials, Employees, โฆ
AgThera focuses on the development of probiotics and live therapeutics within the biotechnology sector. Use the CB Insights Platform to explore AgThera's full profile. AgThera - Products, โฆSee details»
AgThera Inc. - SPEEDA Edge
AgThera Inc. AgThera Inc. is a biotechnology company specializing in animal health. It leverages genetic engineering, machine learning, and biomanufacturing technologies to develop โฆSee details»
AGTHERA โ science to one health
Our mission is to fight global food insecurity by supporting and strengthening the production of sustainable, healthy and affordable animal protein.See details»
AgThera Inc. - Funding, Financials, Valuation & Investors
AgThera Inc. is funded by National Science Foundation. Unlock for free . Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 3. ... How much funding has this โฆSee details»
Team - AGTHERA
Doug Cameron, PhD First Green Partners, former Cargill/Piper JaffraySee details»
Products - AGTHERA
AgThera develops new antimicrobials to eliminate antibiotic-resistant bacteria and hard-to-treat viruses. AgThera has established a platform for launching antimicrobials for use in livestock โฆSee details»
Meet Dirtea And The Brothers Brewing The Functional Mushroom โฆ
1 day ago Entrepreneur brothers Simon and Andrew Salter, after suffering burnout, launched Dirtea, a functional mushroom brand, in 2016. Successful in the UK, Dirtea is expanding to the โฆSee details»
AgThera Inc. - Contacts, Employees, Board Members ... - Crunchbase
General Probiotics develops innovative cellbots, antimicrobial probiotics that eliminate harmful pathogens in livestock.See details»
AgThera Inc. - Crunchbase
General Probiotics develops innovative cellbots, antimicrobial probiotics that eliminate harmful pathogens in livestock.See details»
Amacathera | Transforming therapeutics to make a difference inโฆ
AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health. Our unique, injectable hydrogel platform provides localized, โฆSee details»
Contact โ AGTHERA
Email us at [email protected] Visit us on LinkedIn Visit us on Twitter @Ag_Thera. Call us at 651-503-2696. 1000 Westgate Drive, Suite 1007 St. Paul, MN 55114See details»
Agteria Biotech: Cutting 1% of Global Emissions by 2035
Agteria Biotech is an innovative biotech startup dedicated to mitigating methane emissions in cattle through our groundbreaking compound. By promoting sustainable practices in livestock โฆSee details»
Agtegra | North Dakota and South Dakota Agricultural โฆ
GRAIN. Driven by ever-increasing production, growing global demand and the constant challenge of managing risks posed by weather, Agtegra Cooperative has vigilantly invested in efficient โฆSee details»